Literature DB >> 8736624

Treatment of post-stroke hypertension. A practical guide.

J E O'Connell1, C S Gray.   

Abstract

Cerebrovascular disease is a common cause of morbidity and mortality, especially in the elderly. Treatment of hypertension is effective in the primary prevention of stroke. Hypertension is seen in 80% of acute stroke patients but, by the tenth day after admission to hospital, only one-third are still hypertensive. The clinical significance of post-stroke hypertension is uncertain and its management is a contentious issue. In this article we review current evidence regarding the risks and benefits of the treatment of post-stroke hypertension. The pathophysiology of post-stroke hypertension is described in relation to autoregulation of cerebral blood flow after cerebral infarction or haemorrhage. In the absence of clinical trial data, recommendations for early treatment of post-stroke hypertension are based on a review of expert opinion that immediate, controlled lowering of blood pressure after acute stroke is required only in defined situations such as hypertensive encephalopathy or aortic dissection. There are no reliable data regarding the comparative effects of different hypotensive agents after acute stroke; short-acting vasodilator drugs are recommended if treatment is essential. The benefits of hypotensive therapy in secondary prevention of recurrent stroke are uncertain but the results of large clinical trials in progress should provide helpful guidelines for clinical practice.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8736624     DOI: 10.2165/00002512-199608060-00002

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  44 in total

1.  Who goes home? Predictive factors in stroke recovery.

Authors:  S Henley; S Pettit; A Todd-Pokropek; A Tupper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-01       Impact factor: 10.154

2.  Cerebrovascular consequences of hypertension.

Authors:  S Strandgaard; O B Paulson
Journal:  Lancet       Date:  1994-08-20       Impact factor: 79.321

Review 3.  Hypertension in the elderly.

Authors:  N E Bennet
Journal:  Lancet       Date:  1994-08-13       Impact factor: 79.321

4.  Factors influencing outcome and length of stay in a stroke rehabilitation unit. Part 1. Analysis of 248 unscreened patients--medical and functional prognostic indicators.

Authors:  J S Feigenson; F H McDowell; P Meese; M L McCarthy; S D Greenberg
Journal:  Stroke       Date:  1977 Nov-Dec       Impact factor: 7.914

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  Factors influencing admission blood pressure levels in patients with acute stroke.

Authors:  B Carlberg; K Asplund; E Hägg
Journal:  Stroke       Date:  1991-04       Impact factor: 7.914

7.  The prognostic value of admission blood pressure in patients with acute stroke.

Authors:  B Carlberg; K Asplund; E Hägg
Journal:  Stroke       Date:  1993-09       Impact factor: 7.914

8.  Hazards of therapy for excessive hypertension in acute stroke.

Authors:  M Britton; U de Faire; C Helmers
Journal:  Acta Med Scand       Date:  1980

9.  Blood pressure after stroke. A one-year follow-up study.

Authors:  A Carlsson; M Britton
Journal:  Stroke       Date:  1993-02       Impact factor: 7.914

10.  Changes of circadian blood pressure patterns after hemodynamic and thromboembolic brain infarction.

Authors:  D Sander; J Klingelhöfer
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

View more
  2 in total

1.  Home blood pressure monitoring.

Authors:  Pippa Oakeshott; Linzie Long; Chiara Morrison
Journal:  Br J Gen Pract       Date:  2009-04       Impact factor: 5.386

Review 2.  Stroke pathophysiology: management challenges and new treatment advances.

Authors:  J Jordán; I Ikuta; J García-García; S Calleja; T Segura
Journal:  J Physiol Biochem       Date:  2007-09       Impact factor: 5.080

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.